Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2020
Dosimetry-Driven Quality Measure of Brain Pseudo Computed Tomography Generated From Deep Learning for MRI-Only Radiation Therapy Treatment Planning
Emilie Alvarez Andres, Lucas Fidon, Maria Vakalopoulou, et al.
Scientific Reports
|
July 25, 2020
Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics
Alexandre Carré, Guillaume Klausner, Myriam Edjlali, et al.
The Lancet. Oncology
|
August 19, 2018
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
Roger Sun, Elaine Johanna Limkin, Maria Vakalopoulou, et al.
Current Oncology Reports
|
February 9, 2026
PET Imaging in Head and Neck Squamous Cell Carcinoma: from Staging to Response Assessment
Arnaud Beddok, Conor M Prendergast, Romain-David Seban, et al.
Radiology
|
December 6, 2022
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging
Laurent Dercle, Shawn Sun, Romain-David Seban, et al.
Radiology
|
February 21, 2023
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging
Laurent Dercle, Shawn Sun, Romain-David Seban, et al.
Journal for Immunotherapy of Cancer
|
August 22, 2020
Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma
Celine Boutros, Nathalie Chaput-Gras, Emilie Lanoy, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 26, 2023
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers
Stephane Niyoteka, Romain-David Seban, Rahimeh Rouhi, et al.
Insights Into Imaging
|
March 7, 2022
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC
Raffaella Fiamma Cabini, Francesca Brero, Andrea Lancia, et al.
Molecular Cancer
|
March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2020
Dosimetry-Driven Quality Measure of Brain Pseudo Computed Tomography Generated From Deep Learning for MRI-Only Radiation Therapy Treatment Planning
Emilie Alvarez Andres, Lucas Fidon, Maria Vakalopoulou, et al.
Scientific Reports
|
July 25, 2020
Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics
Alexandre Carré, Guillaume Klausner, Myriam Edjlali, et al.
The Lancet. Oncology
|
August 19, 2018
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
Roger Sun, Elaine Johanna Limkin, Maria Vakalopoulou, et al.
Current Oncology Reports
|
February 9, 2026
PET Imaging in Head and Neck Squamous Cell Carcinoma: from Staging to Response Assessment
Arnaud Beddok, Conor M Prendergast, Romain-David Seban, et al.
Radiology
|
December 6, 2022
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging
Laurent Dercle, Shawn Sun, Romain-David Seban, et al.
Radiology
|
February 21, 2023
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging
Laurent Dercle, Shawn Sun, Romain-David Seban, et al.
Journal for Immunotherapy of Cancer
|
August 22, 2020
Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma
Celine Boutros, Nathalie Chaput-Gras, Emilie Lanoy, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 26, 2023
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers
Stephane Niyoteka, Romain-David Seban, Rahimeh Rouhi, et al.
Insights Into Imaging
|
March 7, 2022
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC
Raffaella Fiamma Cabini, Francesca Brero, Andrea Lancia, et al.
Molecular Cancer
|
March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Page
of 6